Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Schedules Conference Call for Friday, February 27 to Discuss Fourth Quarter and Full Year 2003 Financial Results and Update Forward- Looking Financial Guidance
Integra LifeSciences Schedules Conference Call for Friday, February 27 to Discuss Fourth Quarter and Full Year 2003 Financial Results and Update Forward- Looking Financial Guidance PLAINSBORO, N.J.--(BUSINESS WIRE)--Feb. 13, 2004--Integra LifeSciences Holdings Corporation (Nasdaq:IART) has
View HTML
Toggle Summary Integra LifeSciences Announces Acquisition of Fleetwood Medical's Sparta Implants, Disposables and Instruments
Integra LifeSciences Announces Acquisition of Fleetwood Medical's Sparta Implants, Disposables and Instruments PLAINSBORO, N.J., Feb. 3, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired the Sparta line of disposable critical care
View HTML
Toggle Summary Integra LifeSciences' JARIT Surgical Instruments Awarded Surgical Instrument Agreements by Premier, Inc.
Integra LifeSciences' JARIT Surgical Instruments Awarded Surgical Instrument Agreements by Premier, Inc. PLAINSBORO, N.J., Jan. 16, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Premier Inc. (Premier) has selected JARIT® Surgical Instruments as
View HTML
Toggle Summary Integra LifeSciences Announces Acquisition of Reconstructive Technologies, Inc.
Integra LifeSciences Announces Acquisition of Reconstructive Technologies, Inc. Plainsboro, New Jersey, January 15, 2004 -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that it has acquired the assets of Reconstructive Technologies, Inc.
View HTML
Toggle Summary Integra LifeSciences Announces Acquisition of R&B Surgical Solutions' Line of Neurosurgical Instruments
Integra LifeSciences Announces Acquisition of R&B Surgical Solutions' Line of Neurosurgical Instruments Plainsboro, New Jersey, January 14, 2004 -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that JARIT Surgical Instruments has acquired the R&B instrument line from R&B
View HTML
Toggle Summary Integra LifeSciences' JARIT® Surgical Instruments Awarded Surgical Instrument Agreement by HealthTrust Purchasing Group, L.P.
Integra LifeSciences' JARIT® Surgical Instruments Awarded Surgical Instrument Agreement by HealthTrust Purchasing Group, L.P. Plainsboro, New Jersey, November 13, 2003 -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that JARIT® Surgical Instruments has been
View HTML
Toggle Summary Integra LifeSciences To Host Analyst Forum on November 18, 2003
Integra LifeSciences To Host Analyst Forum on November 18, 2003 PLAINSBORO, N.J.--(BUSINESS WIRE)--Nov. 3, 2003--Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will host an Analyst Forum on Tuesday, November 18, 2003 at 3:00 PM Eastern Time at the Hilton Times
View HTML
Toggle Summary Integra LifeSciences Reports Record Operating Earnings and Revenues for the Third Quarter 2003(PDF)
Integra LifeSciences Reports Record Operating Earnings and Revenues for the Third Quarter 2003(PDF)
View HTML
Toggle Summary Integra LifeSciences Agrees to Acquire Spinal Specialties from I-Flow Corporation
Integra LifeSciences Agrees to Acquire Spinal Specialties from I-Flow Corporation Plainsboro, NJ / October 28, 2003 / -- Integra LifeSciences Holdings Corporation (NASDAQ: IART - news) announced today that it has agreed to acquire Spinal Specialties, Inc.
View HTML
Toggle Summary Integra LifeSciences Launches New Padgett Model S Dermatome Announces Acquisition of Tissue Technologies, Inc.
Integra LifeSciences Launches New Padgett Model S Dermatome Announces Acquisition of Tissue Technologies, Inc. Plainsboro, New Jersey, October 27, 2003 -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced plans to market and sell the Model S Dermatome through its plastic and
View HTML
Toggle Summary Positive Results of DuraGen® Dural Graft Matrix Clinical Experience Involving 110 Patients Presented At NASS Annual Meeting in San Diego
Positive Results of DuraGen® Dural Graft Matrix Clinical Experience Involving 110 Patients Presented At NASS Annual Meeting in San Diego Plainsboro, New Jersey, October 22, 2003 -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that Dr. Pradeep K.
View HTML
Toggle Summary Integra NeuroSciences Launches DuraGen PlusT Dural Graft Matrix
Integra NeuroSciences Launches DuraGen PlusT Dural Graft Matrix Plainsboro, New Jersey, October 20, 2003 -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that Integra NeuroSciences has received 510(k) clearance from the United States Food and Drug Administration to market
View HTML
Toggle Summary Integra NeuroSciences Launches EnDura? No-React® Dural Substitute
Integra NeuroSciences Launches EnDura™ No-React® Dural Substitute Plainsboro, New Jersey, October 20, 2003 -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced plans to market and sell EnDura™ No-React® Dural Substitute, a new suturable product for repair of the dura
View HTML
Toggle Summary Integra LifeSciences Schedules Conference Call for Friday, October 31 to Discuss Third Quarter 2003 Financial Results and Update Forward-Looking Financial Guidance
Integra LifeSciences Schedules Conference Call for Friday, October 31 to Discuss Third Quarter 2003 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J.--(BUSINESS WIRE)--Oct. 17, 2003--Integra LifeSciences Holdings Corporation (NASDAQ:IART) has scheduled a conference
View HTML
Toggle Summary Integra NeuroSciences Donates Camino® Monitoring Systems and LICOX® Brain Tissue Oxygen Monitoring System to US Army Hospital in Iraq
Integra NeuroSciences Donates Camino® Monitoring Systems and LICOX® Brain Tissue Oxygen Monitoring System to US Army Hospital in Iraq Plainsboro, New Jersey, October 13, 2003 -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today responded to a request from the 207th Neurosurgery Team at
View HTML